(MVP) Marvipol S.A. - Ratings and Ratios
Exchange: WAR • Country: Poland • Currency: PLN • Type: Common Stock • ISIN: PLMRVDV00011
MVP: Flats, Commercial Premises, Real Estate
Marvipol Development S.A., a subsidiary of Ksiazek Holding Sp. z.o.o., specializes in real estate development and investment in Poland. Founded in 1996 and headquartered in Warsaw, the company focuses on residential and commercial properties, contributing to Polands urban development. Its operations span from land acquisition to project realization, ensuring a diversified portfolio.
From a technical standpoint, Marvipols stock (Ticker: MVP) on the Warsaw Exchange shows a downward trend, with the SMA 20 and SMA 50 below the SMA 200, indicating bearish momentum. The ATR of 0.16 signals low volatility, suggesting stable price movements.
Fundamentally, the companys market cap of 279.07M PLN reflects its established presence. The P/B ratio of 0.41 may indicate undervaluation, though the negative RoE of -1.91 raises profitability concerns. The P/S ratio of 1.30 suggests moderate valuation, while the high P/E of 47.86 could signal overvaluation or growth expectations.
Additional Sources for MVP Stock
MVP Stock Overview
| Market Cap in USD | 72m |
| Sector | Real Estate |
| Industry | Real Estate - Development |
| GiC Sub-Industry | Real Estate Development |
| IPO / Inception |
MVP Stock Ratings
| Growth 5y | 40.6% |
| Fundamental | 17.2% |
| Dividend | 78.5% |
| Rel. Strength Industry | -11.7 |
| Analysts | - |
| Fair Price Momentum | 7.43 PLN |
| Fair Price DCF | 43.49 PLN |
MVP Dividends
| Dividend Yield 12m | 15.70% |
| Yield on Cost 5y | 45.11% |
| Annual Growth 5y | 44.20% |
| Payout Consistency | 50.0% |
MVP Growth Ratios
| Growth Correlation 3m | 73.6% |
| Growth Correlation 12m | -85% |
| Growth Correlation 5y | 62.8% |
| CAGR 5y | 23.11% |
| CAGR/Max DD 5y | 0.52 |
| Sharpe Ratio 12m | -0.18 |
| Alpha | -10.08 |
| Beta | 0.36 |
| Volatility | 27.29% |
| Current Volume | 3.6k |
| Average Volume 20d | 6.9k |
As of March 15, 2025, the stock is trading at PLN 6.62 with a total of 3,617 shares traded.
Over the past week, the price has changed by -0.30%, over one month by +4.42%, over three months by +7.12% and over the past year by -3.04%.
Neither. Based on ValueRay Fundamental Analyses, Marvipol S.A. is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.18 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MVP as of March 2025 is 7.43. This means that MVP is currently undervalued and has a potential upside of +12.24% (Margin of Safety).
Marvipol S.A. has no consensus analysts rating.
According to ValueRays Forecast Model, MVP Marvipol S.A. will be worth about 8 in March 2026. The stock is currently trading at 6.62. This means that the stock has a potential upside of +21.15%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 9.3 | 40.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8 | 21.1% |